Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Working Capital Changes (2020 - 2025)

RxSight's Other Working Capital Changes history spans 6 years, with the latest figure at $881000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 56.62% year-over-year to $881000.0; the TTM value through Dec 2025 reached $4.1 million, down 13.95%, while the annual FY2025 figure was $179377.0, 1634.45% up from the prior year.
  • Other Working Capital Changes reached $881000.0 in Q4 2025 per RXST's latest filing, up from $74757.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $2.0 million in Q4 2024 to a low of -$346000.0 in Q4 2021.
  • Average Other Working Capital Changes over 5 years is $279343.0, with a median of $63361.0 recorded in 2023.
  • Peak YoY movement for Other Working Capital Changes: surged 1209.98% in 2023, then plummeted 2723.97% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$346000.0 in 2021, then soared by 338.15% to $824000.0 in 2022, then surged by 69.17% to $1.4 million in 2023, then soared by 45.7% to $2.0 million in 2024, then crashed by 56.62% to $881000.0 in 2025.
  • Per Business Quant, the three most recent readings for RXST's Other Working Capital Changes are $881000.0 (Q4 2025), $74757.0 (Q3 2025), and $7811.0 (Q2 2025).